RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q2 2023
Top Holdings62 positions
IMMUNOCORE HLDGS PLC ADS | 6M | $361.5M | 6.9% | $42.95 | +33.91% | 10 qtrssince 2021-Q1 | Increased 65 |
ROCKET PHARMACEUTICALS INC | 17.7M | $351.5M | 6.7% | $18.79 | +6.69% | 18 qtrssince 2019-Q1 | Unchanged 0 |
ALNYLAM PHARMACEUTICALS INC | 1.7M | $319.7M | 6.1% | $94.58 | +102.01% | 18 qtrssince 2019-Q1 | Unchanged 0 |
AXSOME THERAPEUTICS INC | 4.3M | $307.9M | 5.9% | $61.01 | +19.85% | 18 qtrssince 2019-Q1 | Increased 68 |
PTC THERAPEUTICS INC | 7.2M | $294.3M | 5.6% | $43.80 | -5.87% | 18 qtrssince 2019-Q1 | Increased 61 |
ULTRAGENYX PHARMACEUTICAL INC COM | 5.4M | $249.3M | 4.7% | $54.63 | -15.56% | 7 qtrssince 2021-Q4 | Increased 70 |
MASIMO CORP | 1.5M | $247.1M | 4.7% | $174.28 | -4.97% | 18 qtrssince 2019-Q1 | Unchanged 0 |
ACADIA PHARMACEUTICALS INC | 9.8M | $234.3M | 4.5% | $17.85 | +34.15% | 5 qtrssince 2022-Q2 | Increased 66 |
Penumbra Inc. | 673,371 | $231.7M | 4.4% | $262.94 | +29.45% | 8 qtrssince 2021-Q3 | Unchanged 0 |
BRUKER CORP | 3M | $218.8M | 4.2% | $74.17 | -2.48% | 2 qtrssince 2023-Q1 | Increased 91 |
ARGENX SE | 482,195 | $187.9M | 3.6% | $330.45 | +17.94% | 18 qtrssince 2019-Q1 | Unchanged 0 |
ESTABLISHMENT LABS HLDGS INC COM | 2.5M | $171.1M | 3.3% | $24.97 | +179.06% | 18 qtrssince 2019-Q1 | Increased 58 |
MIRATI THERAPEUTICS INC | 4.5M | $161.6M | 3.1% | — | — | 18 qtrssince 2019-Q1 | Increased 67 |
Thermo Fisher Scientific Inc | 290,334 | $151.5M | 2.9% | $570.15 | -10.46% | 8 qtrssince 2021-Q3 | Unchanged 0 |
PROTAGONIST THERAPEUTICS INC COM | 5.4M | $149.6M | 2.8% | $22.38 | +23.62% | 16 qtrssince 2019-Q3 | Increased 61 |
NATERA INC | 2.6M | $127.1M | 2.4% | $42.77 | +13.76% | 16 qtrssince 2019-Q3 | Unchanged 0 |
Vericel Corporation | 3.3M | $123.7M | 2.4% | $17.89 | +114.53% | 18 qtrssince 2019-Q1 | Unchanged 0 |
CELLDEX THERAPEUTICS INC NEW COM NEW | 3.5M | $117.5M | 2.2% | $16.46 | +110.09% | 13 qtrssince 2020-Q2 | Increased 58 |
| 6.8M | $112.2M | 2.1% | — | — | 15 qtrssince 2019-Q4 | Increased 61 | |
HORIZON THERAPEUTICS PUB L | 1M | $102.9M | 2.0% | — | — | 1 qtr | New 68 |
RTW INVESTMENTS, LP manages $5.3B across 62 positions as of Q2 2023. Top holdings: IMCR (6.9%), RCKT (6.7%), ALNY (6.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 10 new positions, 8 exits, 19 increased. Top move: BRKR (INCREASED, conviction 91). Portfolio: $5.3B across 62 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR